Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Market Update

Julia Lee
March 6, 2018

Market Update

Julia Lee
March 6, 2018

Market Update

Julia Lee
March 2, 2018

Equity Investor

Julia Lee
February 27, 2018

Market Update

Julia Lee
February 21, 2018

Equity Investor 19 February

Julia Lee
February 20, 2018

Market Update

Julia Lee
February 19, 2018

Weekly Wrap 16 February

Julia Lee
February 16, 2018

Market Update

Julia Lee
February 14, 2018

Equity Investor 12 February

Julia Lee
February 13, 2018

Weekly Wrap 9 February

Julia Lee
February 9, 2018

Equity Investor 5 February

Julia Lee
February 6, 2018